Bio-Techne (TECH) FY2025 results: revenue $1.2 billion, up 5.2% on the year
Bio-Techne Corp. (TECH) reported revenue of $1.2 billion for fiscal 2025, the year ended 30 June 2025, up 5.2% on the year before. Net income was $73 million, down 56.3%, and diluted earnings per share $0.46. The figures are the company's own, from the 10-K it filed with the SEC on 22 August 2025.
Revenue
$1.2 billion
+5.2% on the year
FY2018FY2025
Operating margin
8.4%
17.8% a year earlier
FY2018FY2025
Net income
$73 million
-56.3% on the year
FY2018FY2025
Diluted EPS
$0.46
-56.2% on the year
FY2018FY2025
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Operating cash flow
288
299
254
-3.8%
Capital expenditure
31.0
62.9
38.2
-50.7%
Free cash flow
257
236
216
+8.7%
Free cash flow margin
21.0%
20.4%
19.0%
Cash from investing
-35.2
-203
-266
Cash from financing
-254
-122
22.6
Depreciation and amortisation
110
112
107
-1.6%
Share-based compensation
40.8
38.0
39.2
+7.3%
Buybacks
276
80.0
19.6
+244.5%
Dividends paid
50.4
50.4
50.3
-0.1%
Dividend per share
$0.32
$0.32
$0.32
0.0%
Diluted shares, weighted
160m
161m
162m
-0.7%
Shares outstanding at period end
155m
158m
158m
-2.1%
Balance sheet
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Shareholders' equity
1,919
2,069
1,967
-7.3%
Debt
346
319
350
+8.5%
Operating lease liabilities
84.0
87.6
93.8
-4.2%
Other liabilities
209
228
228
-8.4%
Total liabilities and equity
2,558
2,704
2,639
-5.4%
Fixed assets
246
251
226
-2.2%
Goodwill
981
973
873
+0.9%
Intangible assets
366
507
535
-27.9%
Investments
n/a
1.1
23.7
Cash and equivalents
162
152
181
+6.8%
Receivables
207
241
218
-14.3%
Inventory
189
180
172
+5.4%
Other assets
407
399
411
+2.0%
Total assets
2,558
2,704
2,639
-5.4%
10-K for the year ended 30 June 2025, filed 22 August 2025: the filing.